BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23125906)

  • 1. Efficacy and safety of vildagliptin in clinical practice-results of the PROVIL-study.
    Blüher M; Kurz I; Dannenmaier S; Dworak M
    World J Diabetes; 2012 Sep; 3(9):161-9. PubMed ID: 23125906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of a single-pill combination of vildagliptin and metformin in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial.
    Odawara M; Yoshiki M; Sano M; Hamada I; Lukashevich V; Kothny W
    Diabetes Ther; 2015 Mar; 6(1):17-27. PubMed ID: 25691359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vildagliptin efficacy in combination with metformin among Jordanian patients with type 2 diabetes mellitus inadequately controlled with metformin.
    Al Omari M; Khader Y; Dauod AS; Beni Yonis OA; Khassawneh AH
    J Drug Assess; 2016; 5(1):29-33. PubMed ID: 27994943
    [No Abstract]   [Full Text] [Related]  

  • 4. Real-life efficacy and safety of vildagliptin compared with sulfonylureas as add-on to metformin in patients with type 2 diabetes mellitus in Germany.
    Göke R; Gruenberger JB; Bader G; Dworak M
    Curr Med Res Opin; 2014 May; 30(5):785-9. PubMed ID: 24328429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the Effectiveness and Safety of Vildagliptin Add-On to Metformin Versus Other Oral Dual Antidiabetes Agents in Patients with Type 2 Diabetes: The China Prospective Diabetes Study.
    Zang L; Han Y; Chen L; Hu D; Jin H; Yang N; Shi X; Liang L; Liu M; Fan H; Li Q; Mu Y
    Diabetes Ther; 2019 Aug; 10(4):1391-1405. PubMed ID: 31222594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-life effectiveness and tolerability of vildagliptin and other oral glucose-lowering therapies in patients with type 2 diabetes in Germany.
    Göke R; Bader G; Dworak M
    Diabetes Ther; 2014 Jun; 5(1):183-91. PubMed ID: 24643724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy.
    Ferrannini E; Fonseca V; Zinman B; Matthews D; Ahrén B; Byiers S; Shao Q; Dejager S
    Diabetes Obes Metab; 2009 Feb; 11(2):157-66. PubMed ID: 19125777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the Efficacy, Tolerability and Side Effect Profile of Vildagliptin-Metformin with Metformin-GlibenclamideMamong Nigerian.
    Uloko AT; Salawu OA; Uloko AE; Gezawa ID
    West Afr J Med; 2021 Aug; 38(8):756-761. PubMed ID: 34503324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of vildagliptin, sitagliptin, and linagliptin as add-on therapy in Chinese patients with T2DM inadequately controlled with dual combination of insulin and traditional oral hypoglycemic agent.
    Tang YZ; Wang G; Jiang ZH; Yan TT; Chen YJ; Yang M; Meng LL; Zhu YJ; Li CG; Li Z; Yu P; Ni CL
    Diabetol Metab Syndr; 2015; 7():91. PubMed ID: 26500706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of vildagliptin relative to sulfonylurea as dual therapy with metformin (or as monotherapy) in Muslim patients with type 2 diabetes fasting during Ramadan in the Middle East: the VIRTUE study.
    Hassoun AA; Al-Arouj M; Ibrahim M
    Curr Med Res Opin; 2017 Jan; 33(1):161-167. PubMed ID: 27684469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of combination therapy with vildagliptin and metformin vs. metformin monotherapy for Type 2 Diabetes Mellitus therapy: a meta-analysis.
    Ding Y; Liu Y; Qu Y; Lin M; Dong F; Li Y; Cao L; Lin S
    Eur Rev Med Pharmacol Sci; 2022 Apr; 26(8):2802-2817. PubMed ID: 35503625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness, safety, and tolerability of vildagliptin or vildagliptin/metformin combination in patients with type 2 diabetes uncontrolled on insulin therapy in a real-world setting in Egypt: The OMEGA study.
    El Ebrashy I; El Kafrawy N; Raouf R; Yousry D
    Diabetes Res Clin Pract; 2020 Apr; 162():108042. PubMed ID: 32006641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of Vildagliptin as an Add-on to Insulin with or without Metformin in Japanese Patients with Type 2 Diabetes Mellitus: A 12-week, Double-Blind, Randomized Study.
    Hirose T; Suzuki M; Tsumiyama I
    Diabetes Ther; 2015 Dec; 6(4):559-571. PubMed ID: 26620049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of vildagliptin as add-on treatment in patients with type 2 diabetes mellitus: insights from long-term clinical studies in Japan.
    Odawara M; Sagara R
    J Diabetes Metab Disord; 2015; 15():21. PubMed ID: 27382546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Vildagliptin as Add-on to Metformin in Japanese Patients with Type 2 Diabetes Mellitus.
    Odawara M; Hamada I; Suzuki M
    Diabetes Ther; 2014 Jun; 5(1):169-81. PubMed ID: 24604395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient preference and tolerability of a DPP-4 inhibitor versus a GLP-1 analog in patients with type 2 diabetes mellitus inadequately controlled with metformin: a 24-week, randomized, multicenter, crossover study.
    Lüdemann J; Dütting ED; Dworak M
    Ther Adv Endocrinol Metab; 2015 Aug; 6(4):141-8. PubMed ID: 26301063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and Tolerability of Vildagliptin and the Single Pill Combination of Vildagliptin and Metformin in "Real-World" Management of Type 2 Diabetes Mellitus: The G-FORCE Study.
    Van Gaal L; Hermans MP; Daci E; Denhaerynck K; De Meester L; MacDonald K; Abraham I; Vancayzeele S; Maris M
    Diabetes Ther; 2019 Jun; 10(3):965-979. PubMed ID: 30919316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacokinetics and pharmacodynamics of vildagliptin.
    He YL
    Clin Pharmacokinet; 2012 Mar; 51(3):147-62. PubMed ID: 22339447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vildagliptin-insulin combination improves glycemic control in Asians with type 2 diabetes.
    Kozlovski P; Foley J; Shao Q; Lukashevich V; Kothny W
    World J Diabetes; 2013 Aug; 4(4):151-6. PubMed ID: 23961326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translating science into clinical practice: focus on vildagliptin in combination with metformin.
    Barnett AH
    Diabetes Obes Metab; 2009 May; 11 Suppl 2():18-26. PubMed ID: 19385980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.